[go: up one dir, main page]

CN109371167A - Genetic elements and the application of frameshift mutation are generated for detecting CRISPR/Cas9 gene editing system cutting gene - Google Patents

Genetic elements and the application of frameshift mutation are generated for detecting CRISPR/Cas9 gene editing system cutting gene Download PDF

Info

Publication number
CN109371167A
CN109371167A CN201811320658.5A CN201811320658A CN109371167A CN 109371167 A CN109371167 A CN 109371167A CN 201811320658 A CN201811320658 A CN 201811320658A CN 109371167 A CN109371167 A CN 109371167A
Authority
CN
China
Prior art keywords
gene
genetic elements
reporter gene
carrier
frameshift mutation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201811320658.5A
Other languages
Chinese (zh)
Inventor
鲁文静
兰峰
张治宇
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BEIJING CELLAPY BIOTECHNOLOGY Co Ltd
Original Assignee
BEIJING CELLAPY BIOTECHNOLOGY Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BEIJING CELLAPY BIOTECHNOLOGY Co Ltd filed Critical BEIJING CELLAPY BIOTECHNOLOGY Co Ltd
Priority to CN201811320658.5A priority Critical patent/CN109371167A/en
Publication of CN109371167A publication Critical patent/CN109371167A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102Mutagenizing nucleic acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90Stable introduction of foreign DNA into chromosome
    • C12N15/902Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/907Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00Nucleic acids vectors
    • C12N2800/10Plasmid DNA
    • C12N2800/106Plasmid DNA for vertebrates
    • C12N2800/107Plasmid DNA for vertebrates for mammalian
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2810/00Vectors comprising a targeting moiety
    • C12N2810/10Vectors comprising a non-peptidic targeting moiety

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Cell Biology (AREA)
  • Mycology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The invention discloses a kind of Genetic elements and applications that frameshift mutation is generated for detecting CRISPR/Cas9 gene editing system cutting gene.The Genetic elements include the promoter effectively connected, the first reporter gene, REST gene, SV40pA gene, S silencer, the second reporter gene and terminator, wherein, it can be inserted between promoter and the first reporter gene by cutting target dna sequence, first reporter gene is different from the second reporter gene, and the expression of REST gene is able to suppress the expression of the second reporter gene behind S silencer.The Genetic elements that frameshift mutation is generated for detecting CRISPR/Cas9 gene editing system cutting gene can be used as core element and be connected in carrier, it can be used to the cutting efficiency in living cells identification gRNA intracellular to genome, be the fluorescence phenotype and ease for operation of instant fluorescence phenotype, high stability when the detection is with generation frameshift mutation.

Description

Frameshift mutation is generated for detecting CRISPR/Cas9 gene editing system cutting gene Genetic elements and application
Technical field
The present invention relates to the clone technologies and field of molecular detection in genetic engineering, in particular to a kind of use Genetic elements and the application of frameshift mutation are generated in detection CRISPR/Cas9 gene editing system cutting gene.
Background technique
The short palindrome repetitive sequence in the interval of regular cluster (Clustered Regularly Interspaced Short Palindromic Repeats, CRISPR) it is one of most of bacteriums and archeobacteria acquired immunity mode.2012, Jinek etc. operates genomic DNA using CRISPR/Cas9 gene editing system, and confirms that this system can be Active somatic cell realizes the gene editing that RNA is mediated.So far, CRISPR/Cas9 gene editing system is widely used in target gene Editor.Especially in inductivity versatile stem cell (Induced Pluripotent Stem cells, iPS cells) or embryo Application in tire stem cell (Embryonic Stem Cell, ESCs), uses CRISPR/Cas9 gene editing system modification base Because the cell line for organizing obtained can imitate gene patient, the research and development for purpose new drug, specific drug;Or inactivation specific mutation Gene achievees the purpose that gene editing treats disease.On the other hand, since CRISPR/Cas9 gene editing system is that RNA is mediated , thus gRNA whether have single-minded cleavage site be it is most crucial, restrict CRISPR/Cas9 gene editing system and use Factor is one of the key element for determining foregoing purpose realization.Therefore, gRNA design quality determines what target gene group was cut Efficiency;The gRNA of specificity can reduce the probability that misses the target, and improve the accuracy of gene editing, avoid the editor of extra false.Institute To need a kind of detection method to carry out gRNA designed by Rapid identification and generate frameshift mutation to the cutting efficiency of genome and editor How genome base sequence afterwards is distributed.
Summary of the invention
The present invention is intended to provide a kind of generate frameshift mutation for detecting CRISPR/Cas9 gene editing system cutting gene Genetic elements and application, with provide it is a kind of quickly, can be in living cells identification gRNA intracellular to the cutting efficiency of genome Method.
To achieve the goals above, according to an aspect of the invention, there is provided it is a kind of for detecting CRISPR/Cas9 base Because editing system cutting gene generates the Genetic elements (CRISPR/Cas9Indel Assay system, CIAs) of frameshift mutation. CIAs Genetic elements include the promoter effectively connected, the first reporter gene, REST gene, SV40pA gene, S silencer, Two reporter genes and terminator, wherein it is can be inserted between promoter and the first reporter gene by cutting target dna sequence, First reporter gene is different from the second reporter gene, and the expression of REST gene is able to suppress the second reporter gene behind silencer Expression.
Further, Genetic elements further include the enhancer effectively connected.
Further, enhancer is cmv enhancer.
Further, the first reporter gene is red fluorescent protein gene, and the second reporter gene is green fluorescent protein base Cause.
Further, promoter is EF1 promoter, and terminator is beta-globin polyadenylic acid.
Further, Genetic elements contain double enzyme site, and double enzyme site is located between promoter and the first report, quilt Cutting target dna sequence is connected between double enzyme site.
Further, double enzyme site is Xba I and Kpn I restriction enzyme site.
Further, REST gene and the amplification of S silencer are in source of people H9 cell line.
Further, Genetic elements have the nucleotide sequence as shown in SEQ ID NO:1.
According to another aspect of the present invention, it provides a kind of for detecting CRISPR/Cas9 gene editing system cutting base Because generating the carrier of frameshift mutation.The carrier includes any of the above-described kind of Genetic elements.
Further, carrier is pUC serial carrier, pEASY, pBlueScriptII or pBR322.
According to another aspect of the present invention, a kind of host cell is provided.The host cell includes any of the above-described kind and is used for Detect the carrier that CRISPR/Cas9 gene editing system cutting gene generates frameshift mutation.
Further, host cell is Escherichia coli.
In accordance with a further aspect of the present invention, a kind of detection CRISPR/Cas9 gene editing system cutting gene production is provided The method of raw frameshift mutation.This method is to cut base for detecting CRISPR/Cas9 gene editing system using any of the above-described kind Carrier because generating frameshift mutation is detected.
Further, comprising the following steps: then S1 turns by any of the above-described kind of carrier insertion by cutting target dna sequence Dye is transferred to the carrier (DNA sequence dna comprising expressing Cas9 albumen) for being mounted with gRNA into cell line;S2, observation first The expression of reporter gene and the second reporter gene judges according to the expression of the first reporter gene and the second reporter gene Whether gRNA produces frameshift mutation to the editor of target dna sequence.
Further, further includes: when the second reporter gene normal expression, be judged as CRISPR/Cas9 gene editing system System cutting gene produces frameshift mutation, and expands target dna sequence and be sequenced.
Further, cell line is HEK293 cell line.
The Genetic elements of frameshift mutation are generated (referred to as detecting CRISPR/Cas9 gene editing system cutting gene CIAs it) can be used as core element to be connected in carrier, can be used to imitate the cutting of genome in living cells identification gRNA intracellular Rate, the detection have generate frameshift mutation when be instant fluorescence phenotype, high stability fluorescence phenotype and ease for operation, and The vector construction has the remarkable advantage of the genetic manipulations such as simple, quick, time saving, laborsaving.
Detailed description of the invention
The accompanying drawings constituting a part of this application is used to provide further understanding of the present invention, and of the invention shows Examples and descriptions thereof are used to explain the present invention for meaning property, does not constitute improper limitations of the present invention.In the accompanying drawings:
Fig. 1 shows Genetic elements CIAs composition schematic diagram.;
Fig. 2 a and 2b are respectively the plasmid map of the CIAs-pUC19 that Genetic elements CIAs of the invention is loaded and pCIAs.
Fig. 3 a and 3b points of target-pCIAs and target-1-pCIAs to load target DNA sequence.
Fig. 4 a, 4b, 4c and 4d are respectively the plasmid map for loading gRNA sequence.
Fig. 5 a, 5b, 5c and 5d are respectively that the light microscopic and fluorescence photo of bacterial strain to be edited are edited and do not had to target DNA.
Specific embodiment
It should be noted that in the absence of conflict, the features in the embodiments and the embodiments of the present application can phase Mutually combination.The present invention will be described in detail below with reference to the accompanying drawings and embodiments.
For some technical problems existing in the prior art, the present invention provides a kind of detection CRISPR/Cas9 gene volume The system of collecting cutting gene generates Genetic elements, carrier, host cell and the method for frameshift mutation.
A kind of typical embodiment according to the present invention provides a kind of for detecting CRISPR/Cas9 gene editing system Cut the Genetic elements that gene generates frameshift mutation.The Genetic elements include the promoter effectively connected, the first reporter gene, REST gene, SV40pA gene, S silencer, the second reporter gene and terminator, wherein promoter and the first reporter gene base It is can be inserted into because between by cutting target dna sequence, the first reporter gene is different from the second reporter gene, the expression energy of REST gene Enough inhibit the expression of the second reporter gene behind silencer.
" effectively connection " the i.e. conventional sense of field of biotechnology in the present invention, that is, the Genetic elements after connecting can rise To its scheduled effect.
Target dna sequence is connected in said gene element, and gRNA/Cas9 complex cuts target dna sequence and generates When frameshift mutation, the first reporter gene and REST gene can also generate frameshift mutation, be that cannot express correct first report base Because of-REST fusion protein, the albumen of the first reporter gene can not be as generated, the second report behind S silencer can not be inhibited The expression of gene.At this moment, the albumen of the second reporter gene can normal expression, can make host cell line generate second report The signal of gene.
Target dna sequence is connected in Genetic elements CIAs, and gRNA/Cas9 complex cutting target dna sequence does not produce When raw frameshift mutation, the first reporter gene and the correct first reporter gene-REST fusion protein of REST gene expression are as produced The albumen of raw first reporter gene, while S silencer inhibits the expression of the second reporter gene below.At this moment, the first reporter gene Can normal expression, and the second reporter gene is not expressed, so the signal of the first reporter gene.
When the first reporter gene is red fluorescent protein gene, and the second reporter gene is green fluorescence protein gene, mesh Mark DNA sequence dna is connected in Genetic elements CIAs, when gRNA/Cas9 complex cuts target dna sequence generation frameshift mutation, Genetic elements red fluorescent protein and REST gene can also generate frameshift mutation, be that cannot express correct red fluorescence-REST Fusion protein as can not generate red fluorescent protein and not inhibit the expression of gene green fluorescent protein behind silencer.This When, green fluorescent protein can normal expression, can make host generate green fluorescence.Target dna sequence is connected to gene In element CIAs, when gRNA/Cas9 complex cutting target dna sequence does not generate frameshift mutation, Genetic elements red fluorescence egg The white and correct red fluorescence-REST fusion protein of REST gene expression, as generation red fluorescent protein and inhibition silencer The expression of gene green fluorescent protein below.At this moment, red fluorescent protein can normal expression, and green fluorescence is not table It reaches, so host generates red fluorescence.
The sequence that said gene element CIAs is included by gene chemical synthesis or can be amplified from and contain this Genetic elements Target nucleic acid sequence obtain, and linked together by the method for fusion DNA vaccine or homologous recombination.Composition sequence separate sources, It can be applied to different cell lines.Wherein, a kind of typical embodiment, REST gene and S silencer expand according to the present invention In source of people iPS or H9 cell line, it is more suitable for the gene frameshift mutation detection of human archeocyte system.
Preferably, Genetic elements further include the enhancer effectively connected, and preferred enhancer is cmv enhancer.
A kind of typical embodiment according to the present invention, promoter are EF1 promoter, and terminator is the poly- adenosine of beta-globin Acid.
Convenient for target dna sequence, Genetic elements CIAs contains double enzyme site, and double enzyme site is located at promoter and first Between report, it is connected between double enzyme site by cutting target dna sequence.Preferably, double enzyme site is Xba I and Kpn I restriction enzyme site.
Preferably, Genetic elements CIAs has the nucleotide sequence as shown in SEQ ID NO:1.
SEQ ID NO:1
TGTAAAACGACGGCCAGTGAATTCGACATTGATTATTGACTAGTTATTAATAGTAATCAATTACGGGG TCATTAGTTCATAGCCCATATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCCCGCCTGGCTGACCGCCCA ACGACCCCCGCCCATTGACGTCAATAATGACGTATGTTCCCATAGTAACGCCAATAGGGACTTTCCATTGACGTCA ATGGGTGGAGTATTTACGGTAAACTGCCCACTTGGCAGTACATCAAGTGTATCATATGCCAAGTACGCCCCCTATT GACGTCAATGACGGTAAATGGCCCGCCTGGCATTATGCCCAGTACATGACCTTATGGGACTTTCCTACTTGGCAGT ACATCTACGTATTAGTCATCGCTATTACCATGGAATAGCAACAGACATACAAACTAAAGAATTACAAAAACAAATT ACAAAAATTCAAAATTTTATCGATACTAGTAAGGATCTGCGATCGCTCCGGTGCCCGTCAGTGGGCAGAGCGCACA TCGCCCACAGTCCCCGAGAAGTTGGGGGGAGGGGTCGGCAATTGAACGGGTGCCTAGAGAAGGTGGCGCGGGGTAA ACTGGGAAAGTGATGTCGTGTACTGGCTCCGCCTTTTTCCCGAGGGTGGGGGAGAACCGTATATAAGTGCAGTAGT CGCCGTGAACGTTCTTTTTCGCAACGGGTTTGCCGCCAGAACACAGCTGAAGCTTCGAGGGGCTCGCATCTCTCCT TCACGCGCCCGCCGCCCTACCTGAGGCCGCCATCCACGCCGGTTGAGTCGCGTTCTGCCGCCTCCCGCCTGTGGTG CCTCCTGAACTGCGTCCGCCGTCTAGGTAAGTTTAAAGCTCAGGTCGAGACCGGGCCTTTGTCCGGCGCTCCCTTG GAGCCTACCTAGACTCAGCCGGCTCTCCACGCTTTGCCTGACCCTGCTTGCTCAACTCTACGTCTTTGTTTCGTTT TCTGTTCTGCGCCGTTACAGATCCAAGCTGTGACCGGCGCCTACATGTCTAGANNNNNNNNNNNNNNNNNNNNNNN NNNNNNNGGTACCGTGTCTAAGGGCGAAGAGCTGATTAAGGAGAACATGCACATGAAGCTGTACATGGAGGGCACC GTGAACAACCACCACTTCAAGTGCACATCCGAGGGCGAAGGCAAGCCCTACGAGGGCACCCAGACCATGAGAATCA AGGTGGTCGAGGGCGGCCCTCTCCCCTTCGCCTTCGACATCCTGGCTACCAGCTTCATGTACGGCAGCAAAACCTT CATCAACCACACCCAGGGCATCCCCGACTTCTTTAAGCAGTCCTTCCCTGAGGGCTTCACATGGGAGAGAGTCACC ACATACGAAGACGGGGGCGTGCTGACCGCTACCCAGGACACCAGCCTCCAGGACGGCTGCCTCATCTACAACGTCA AGATCAGAGGGGTGAACTTCCCATCCAACGGCCCTGTGATGCAGAAGAAAACACTCGGCTGGGAGGCCTCCACCGA GATGCTGTACCCCGCTGACGGCGGCCTGGAAGGCAGAAGCGACATGGCCCTGAAGCTCGTGGGCGGGGGCCACCTG ATCTGCAACTTGAAGACCACATACAGATCCAAGAAACCCGCTAAGAACCTCAAGATGCCCGGCGTCTACTATGTGG ACAGAAGACTGGAAAGAATCAAGGAGGCCGACAAAGAAACCTACGTCGAGCAGCACGAGGTGGCTGTGGCCAGATA CTGCGACCTCCCTAGCAAACTGGGGCACAAACTTAATTAAGCCACCCAGGTAATGGGGCAGTCTTCTGGAGGAGGA GGGCTGTTTACCAGCAGTGGCAACATTGGAATGGCCCTGCCTAACGACATGTATGACTTGCATGACCTTTCCAAAG CTGAACTGGCCGCACCTCAGCTTATTATGCTGGCAAATGTGGCCTTAACTGGGGAAGTAAATGGCAGCTGCTGTGA TTACCTGGTCGGTGAAGAAAGACAGATGGCAGAACTGATGCCGGTTGGGGATAACAACTTTTCAGATAGTGAAGAA GGAGAAGGACTTGAAGAGTCTGCTGATATAAAAGGTGAACCTCATGGACTGGAAAACATGGAACTGAGAAGTTTGG AACTCAGCGTCGTAGAACCTCAGCCTGTATTTGAGGCATCAGGTGCTCCAGATATTTACAGTTCAAATAAAGATCT TCCCCCTGAAACACCTGGAGCGGAGGACAAAGGCAAGAGCTCGAAGACCAAACCCTTTCGCTGTAAGCCATGCCAA TATGAAGCAGAATCTGAAGAACAGTTTGTGCATCACATCAGAGTTCACAGTGCTAAGAAATTTTTTGTGGAAGAGA GTGCAGAGAAGCAGGCAAAAGCCAGGGAATCTGGCTCTTCCACTGCAGAAGAGGGAGATTTCTCCAAGGGCCCCAT TCGCTGTGACCGCTGCGGCTACAATACTAATCGATATGATCACTATACAGCACACCTGAAACACCACACCAGAGCT GGGGATAATGAGCGAGTCTACAAGTGTATCATTTGCACATACACAACAGTGAGCGAGTATCACTGGAGGAAACATT TAAGAAACCATTTTCCAAGGAAAGTATACACATGTGGAAAATGCAACTATTTTTCAGACAGAAAAAACAATTATGT TCAGCATGTTAGAACTCATACAGGAGAACGCCCATATAAATGTGAACTTTGTCCTTACTCAAGTTCTCAGAAGACT CATCTAACTAGACATATGCGTACTCATTCAGGTGAGAAGCCATTTAAATGTGATCAGTGCAGTTATGTGGCCTCTA ATCAACATGAAGTAACCCGCCATGCAAGACAGGTTCACAATGGGCCTAAACCTCTTAATTGCCCACACTGTGATTA CAAAACAGCAGATAGAAGCAACTTCAAAAAACATGTAGAGCTACATGTGAACCCACGGCAGTTCAATTGCCCTGTA TGTGACTATGCAGCTTCCAAGAAGTGTAATCTACAGTATCACTTCAAATCTAAGCATCCTACTTGTCCTAATAAAA CAATGGATGTCTCAAAAGTGAAACTAAAGAAAACCAAAAAACGAGAGGCTGACTTGCCTGATAATATTACCAATGA AAAAACAGAAATAGAACAAACAAAAATAAAAGGGGATGTGGCTGGAAAGAAAAATGAAAAGTCCGTCAAAGCAGAG AAAAGAGATGTCTCAAAAGAGAAAAAGCCTTCTAATAATGTGTCAGTGATCCAGGTGACTACCAGAACTCGAAAAT CAGTAACAGAGGTGAAAGAGATGGATGTGCATACAGGAAGCAATTCAGAAAAATTCAGTAAAACTAAGAAAAGCAA AAGGAAGCTGGAAGTTGACAGCCATTCTTTACATGGTCCTGTGAATGATGAGGAATCTTCAACAAAAAAGAAAAAG AAGGTAGAAAGCAAATCCAAAAATAATAGTCAGGAAGTGCCAAAGGGTGACAGCAAAGTGGAGGAGAATAAAAAGC AAAATACTTGCATGAAAAAAAGTACAAAGAAGAAAACTCTGAAAAATAAATCAAGTAAGAAAAGCAGTAAGCCTCC TCAGAAGGAACCTGTTGAGAAGGGATCTGCTCAGATGGACCCTCCTCAGATGGGGCCTGCTCCCACAGAGGCGGTT CAGAAGGGGCCCGTTCAGGTGGAGCCGCCACCTCCCATGGAGCATGCTCAGATGGAGGGTGCCCAGATACGGCCTG CTCCTGACGAGCCTGTTCAGATGGAGGTGGTTCAGGAGGGGCCTGCTCAGAAGGAGCTGCTGCCTCCCGTGGAGCC TGCTCAGATGGTGGGTGCCCAAATTGTACTTGCTCACATGGAGCTGCCTCCTCCCATGGAGACTGCTCAGACGGAG GTTGCCCAAATGGGGCCTGCTCCCATGGAACCTGCTCAGATGGAGGTTGCCCAGGTAGAATCTGCTCCCATGCAGG TGGTCCAGAAGGAGCCTGTTCAGATGGAGCTGTCTCCTCCCATGGAGGTGGTCCAGAAGGAGCCTGTTCAGATAGA GCTGTCTCCTCCCATGGAGGTGGTCCAGAAGGAACCTGTTAAGATAGAGCTGTCTCCTCCCATAGAGGTGGTCCAG AAGGAGCCTGTTCAGATGGAGTTGTCTCCTCCCATGGGGGTGGTTCAGAAGGAGCCTGCTCAGAGGGAGCCACCTC CTCCCAGAGAGCCTCCCCTTCACATGGAGCCAATTTCCAAAAAGCCTCCTCTCCGAAAAGATAAAAAGGAAAAGTC TAACATGCAGAGTGAAAGGGCACGGAAGGAGCAAGTCCTTATTGAAGTTGGCTTAGTGCCTGTTAAAGATAGCTGG CTTCTAAAGGAAAGTGTAAGCACAGAGGATCTCTCACCACCATCACCACCACTGCCAAAGGAAAATTTAAGAGAAG AGGCATCAGGAGACCAAAAATTACTCAACACAGGTGAAGGAAATAAAGAAGCCCCTCTTCAGAAAGTAGGAGCAGA AGAGGCAGATGAGAGCCTACCTGGTCTTGCTGCTAATATCAACGAATCTACCCATATTTCATCCTCTGGACAAAAC TTGAATACGCCAGAGGGTGAAACTTTAAATGGTAAACATCAGACTGACAGTATAGTTTGTGAAATGAAAATGGACA CTGATCAGAACACAAGAGAGAATCTCACTGGTATAAATTCAACAGTTGAAGAACCAGTTTCACCAATGCTTCCCCC TTCAGCAGTAGAAGAACGTGAAGCAGTGTCCAAAACTGCACTGGCATCACCTCCTGCTACAATGGCAGCAAATGAG TCTCAGGAAATTGATGAAGATGAAGGCATCCACAGCCATGAAGGAAGTGACCTAAGTGACAACATGTCAGAGGGTA GTGATGATTCTGGATTGCATGGGGCTCGGCCAGTTCCACAAGAATCTAGCAGAAAAAATGCAAAGGAAGCCTTGGC AGTCAAAGCGGCTAAGGGAGATTTTGTTTGTATCTTCTGTGATCGTTCTTTCAGAAAGGGAAAAGATTACAGCAAA CACCTCAATCGCCATTTGGTTAATGTGTACTATCTTGAAGAAGCAGCTCAAGGGCAGGAGTAAAGCTGAATCTAAG TCGACTTAAGAACCGCTCGAGGCCGGCAAGGCCGGATCCAGACATGATAAGATACATTGATGAGTTTGGACAAACC ACAACTAGAATGCAGTGAAAAAAATGCTTTATTTGTGAAATTTGTGATGCTATTGCTTTATTTGTAACCATTATAA GCTGCAATAAACAAGTTAACAACAACAATTGCATTCATTTTATGTTTCAGGTTCAGGGGGAGGTGTGGGAGGTTTT TTAAAGCAAGTAAAACCTCTACAAATGTGGTATGGCTGATTATGATCTCATTCATCCTTTTCTCCTCGTCCCTCCT TCATTCATTCATAGCCCCCCGCCCTGCCCGCTTCAGCATTTCATTCATTCATTCATTCATTCATTTCCCGGAGCTC CGCTAGCGCACACCCCTTCAGCCGAAGGCCCCAGCGCGCAGGCGCAGGCCGGGAGAGGCAGGCACCCTCCAATCGT CGGGCGTCCTTCCTCCTCCGGGCGGCCGCCCGCTTCCCCATGAATGAACATTGACGTCAATGGGGCGGGGCGCGCC CACGTGACCCCGCGCGCTCCCCTTTATAAGGCGGTGGAGGCGCGGGCGCTGTCCAGCGTGCTGAAGCCGGAGCGAG CTAGCCGCCCGGAGCCGCGCCGACCCAGCTGAGCCCAGCCCACGGGACGCCAGACCTCGACCGTCGCTCCTACCCC GGCCACCGCTCGGAGCCGAGGCGGACGCGTCCCGATCTTCCCCTGTCCCCACCCTGCCCCGACCCTCCTCTCCACC TCTCGCGTCGTGACACCAGCTGGTAAATACTCCGCTGTTCGTCCCTCAAACCCTCGGCAGCCAGCCGTGGGCGTGA GGGAGGGTTCTCTCTCCTCTCGATGGGGGTGTTGCAAACACAGCGGGGAGCCCCCTGGTAAGGGTCCCCGGTAAAC GGGGGAGTCGCAGCTTTTTCTCTTGCTGCTGAAGTCGCCCACGCACCATCCGGGGAGTCCTACGGGGAGGGAGCAG AGATTTTTTTTTCCCCCATATTGCTGCTGCTTAGTACGTGGGCGATGGCAGTGAGATGGCTCAGGGAAGGGGCCGA GGAGGCCCTGGGTAAGCGAGGGCTTCGGGGGTTATTTTCCCATTTACACGGCTCCAGAGATCGGCACAACATCTTC CTCCTTTGCTCCTAAACGTTCCTCTTCTGGGTAAGGTTTGGGGGATCAGGGAAGCCCCGGGTTTCCTGCTGAAAGG TGGGGGAAGGGAACGTAGACCTAGAGAGGGGAATTCTTACAGAAATCCTCTTTTTTTGGTCCCTTCTATTTTTCAG TCTCCGGCAGCCTCTTGGTCATGGTGAGCAAGGGCGAGGAGCTGTTCACCGGGGTGGTGCCCATCCTGGTCGAGCT GGACGGCGACGTAAACGGCCACAAGTTCAGCGTGTCCGGCGAGGGCGAGGGCGATGCCACCTACGGCAAGCTGACC CTGAAGTTCATCTGCACCACCGGCAAGCTGCCCGTGCCCTGGCCCACCCTCGTGACCACCCTGACCTACGGCGTGC AGTGCTTCAGCCGCTACCCCGACCACATGAAGCAGCACGACTTCTTCAAGTCCGCCATGCCCGAAGGCTACGTCCA GGAGCGCACCATCTTCTTCAAGGACGACGGCAACTACAAGACCCGCGCCGAGGTGAAGTTCGAGGGCGACACCCTG GTGAACCGCATCGAGCTGAAGGGCATCGACTTCAAGGAGGACGGCAACATCCTGGGGCACAAGCTGGAGTACAACT ACAACAGCCACAACGTCTATATCATGGCCGACAAGCAGAAGAACGGCATCAAGGTGAACTTCAAGATCCGCCACAA CATCGAGGACGGCAGCGTGCAGCTCGCCGACCACTACCAGCAGAACACCCCCATCGGCGACGGCCCCGTGCTGCTG CCCGACAACCACTACCTGAGCACCCAGTCCGCCCTGAGCAAAGACCCCAACGAGAAGCGCGATCACATGGTCCTGC TGGAGTTCGTGACCGCCGCCGGGATCACTCTCGGCATGGACGAGCTGTACAAGTAAACGCGTGAATTCACTCCTCA GGTGCAGGCTGCCTATCAGAAGGTGGTGGCTGGTGTGGCCAATGCCCTGGCTCACAAATACCACTGAGATCTTTTT CCCTCTGCCAAAAATTATGGGGACATCATGAAGCCCCTTGAGCATCTGACTTCTGGCTAATAAAGGAAATTTATTT TCATTGCAATAGTGTGTTGGAATTTTTTGTGTCTCTCACTCGGAAGGACATATGGGAGGGCAAATCATTTAAAACA TCAGAATGAGTATTTGGTTTAGAGTTTGGCAACATATGCCCATATGCTGGCTGCCATGAACAAAGGTTGGCTATAA AGAGGTCATCAGTATATGAAACAGCCCCCTGCTGTCCATTCCTTATTCCATAGAAAAGCCTTGACTTGAGGTTAGA TTTTTTTTATATTTTGTTTTGTGTTATTTTTTTCTTTAACATCCCTAAAATTTTCCTTACATGTTTTACTAGCCAG ATTTTTCCTCCTCTCCTGACTACTCCCAGTCATAGCTGTCCCTCTTCTCTTATGGAGATCCCTCGACCTGCAGCCC AAGCTTGGCGTAATCATGGTCATAGCTGTTTCCTG。
A kind of typical embodiment according to the present invention provides a kind of for detecting CRISPR/Cas9 gene editing system Cut the carrier that gene generates frameshift mutation.The carrier includes any of the above-described kind of Genetic elements.Genetic elements CIAs can connect Realize that stablizing for CIAs nucleic acid sequence is lost into pUC series or other cloned plasmids or other function property grain or host genome It passes, can be transferred in different hosts and be functioned with different carrier format passenger gene element CIAs.
A kind of typical embodiment according to the present invention, provides a kind of host cell.The host cell includes any of the above-described Kind generates the carrier of frameshift mutation for detecting CRISPR/Cas9 gene editing system cutting gene, such as host cell is big Enterobacteria.The carrier for being used to detect the cutting gene generation frameshift mutation of CRISPR/Cas9 gene editing system is transformed into large intestine In bacillus, plasmid is extracted from positive colony.Genetic elements CIAs can carry out the codon optimization of different plant species, can be not It functions with host cell.
A kind of typical embodiment according to the present invention provides a kind of detection CRISPR/Cas9 gene editing system cutting The method of gene generation frameshift mutation.This method includes using above-mentioned for detecting the cutting of CRISPR/Cas9 gene editing system The carrier that gene generates frameshift mutation is detected.
Preferably, comprising the following steps: above-mentioned carrier is inserted by cutting target dna sequence, then transfects to cell by S1 In system, while being transferred to the carrier for being mounted with gRNA;S2 observes the expression of the first reporter gene and the second reporter gene, root Judge whether gRNA produces shifting to the editor of target dna sequence according to the expression of the first reporter gene and the second reporter gene Code mutation.Preferably, when the second reporter gene normal expression, it is judged as that CRISPR/Cas9 gene editing system cuts gene Frameshift mutation is produced, and expands target dna sequence and is sequenced.Wherein, it is preferred that cell line is HEK293 cell line. HEK293 cell line is easy transfectional cell series, convenient for quickly detection.
Constructing Genetic elements CIAs of the invention facilitates gRNA/Cas9 complex cutting target DNA sequence in identification of cell The frameshift mutation situation generated after column and other possible pairing DNA sequence dnas, further to provide volume intracellular to the gRNA of design Volume information and provide background information for gene editing application.The pCIAs plasmid that the present invention constructs (includes said gene element Carrier, such as: SEQ ID NO:1) can be directly connected to target DNA sequence, transfect into HEK293 cell line, be transferred to simultaneously The carrier of the loading gRNA of design.After 48 hours, determined in fluorescin that fluorescence microscopy microscopic observation cell is expressed Whether gRNA produces frameshift mutation to the editor of target DNA sequence.After extracting DNA for the green fluorescence strain showed, PCR amplification target DNA sequence measures nucleic acid sequence after loading using carrier T, for identifying DNA sequence dna to be edited.
A kind of typical embodiment according to the present invention, Genetic elements CIAs is as shown in Figure 1, synthesized by DNA sequence dna Mode obtain.The CIAs sequence of synthesis needs to load CIAs to pUC19 plasmid by Sanger sequence verification.
A kind of typical embodiment according to the present invention, the application method of functional vector, comprising the following steps: A. is used PCR amplification linearizes CIAs;B. target fragment CIAs is connected in the pPuro plasmid of linearisation and obtains purpose plasmid CIAs-pPuro (or being pCIAs);C. the step B plasmid obtained is converted into Escherichia coli, screens correct clone, And pass through Sanger sequence verification;D. after cutting pCIAs plasmid using Xba I and Kpn I digestion, connection target DNA sequence is extremely PCIAs plasmid.In one embodiment, it is transferred to different target DNA sequences respectively to pCIAs plasmid, and is transferred to gRNA carrier, comes It verifies cleavage activity and causes the base sequence after frameshift mutation.
The pCIAs plasmid can be used as the starting vector of testing goal DNA sequence dna, and the carrier have it is simple, quickly, The remarkable advantage of the genetic manipulations such as time saving, laborsaving, can be used for detecting gRNA to target DNA cleavage activity verifying and it is edited DNA sequence analysis confirmation.
The carrier that the present invention does the detection CRISPR/Cas9 gene editing system cutting gene generation frameshift mutation constructed can After whether being frameshift mutation and generate frameshift mutation with the mutation after the cutting of genome caused by the gRNA of quick detection design Generated base knocks out type and type probability.Method of the present invention can be quick, efficient, instant and stable detection The gRNA/Cas9 complex of design cuts postgenome, and whether the genotype repaired, which meets experiment, is expected, and grinds in gene function Studying carefully aspect has great significance.
In an exemplary embodiment of the invention, the technical advantage of the mechanism of action of Genetic elements CIAs is, by mesh DNA sequence dna load to pCIAs (pCIAs is the title that CIAs is connected on carrier) plasmid after, while turning gRNA carrier extremely In HEK293 cell line, it can quickly detect whether gRNA can cut target DNA sequence in time.Since pCIAs can be carried There is Puro resistance screening gene, so can remove the cell for not being transferred to purpose plasmid after addition puro, reduce high background Disadvantage.
In order to verify the cleavage activity and edited base sequence that Genetic elements CIAs quickly detects gRNA, the present invention In one embodiment, it loads in target DNA sequence to pCIAs, while turning gRNA vector plasmid and going to HEK293 cell together In system.After puro will be screened, the expression of fluorescence microscope reporter gene is used.If cell expression green is glimmering Light indicates that gRNA can cut target DNA sequence;If cell expresses red fluorescence, indicate that gRNA is cannot to cut mesh DNA sequence dna.In addition, target dna sequence base situation to be edited is identified by the DNA for extracting cell line, to analyze Edited result and determine suitable gRNA.
Beneficial effects of the present invention are further illustrated below in conjunction with embodiment.In the present invention for detailed description the step of or Reagent can be realized or be used the conventional reagent of this field using ordinary skill in the art means.
Embodiment 1
In the following embodiments, enzyme used is purchased from NEB, and HEK293 cell line matches the limited public affairs of shellfish biotechnology from Beijing Department.Genetic elements cmv enhancer, EF1 promoter, red fluorescent protein gene, REST gene, SV40pA terminator, S silencing The sequence information of son, green fluorescence protein gene and beta-globin polyadenylic acid comes from ncbi database, and synthesis is public by gold only intelligence Department completes, and (see Fig. 2 a) in reprinting to pUC19 plasmid.It is that Genetic elements CIAs illustrates map with reference to Fig. 1.
The present invention obtains pCIAs plasmid (Fig. 2 b) by genetic manipulation process, and example process is as follows:
The DNA of the plasmid pPuro of 300ng is mixed with 0.5 μ l restriction enzyme Xha I, carries out digestion, 37 DEG C of water-baths 1h obtains linearized vector segment pPuro after recycling.Using CIAs-pUC19 plasmid as template, with CIA-P1 (SEQ ID NO:2) It is primer amplification CIAs sequence with CIA-P2 (SEQ ID NO:3).Above-mentioned 2 segment is connected using SLIC cloning process.By 100ng PPuro and Insert Fragment CIAs according to molar ratio 1:2, handled at room temperature 2.5 minutes using the T4DNA polymerase of 0.5U, Subsequent ice bath is simultaneously converted into Escherichia coli, is coated on containing correct clone is screened on Amp plate, is obtained plasmid pCIAs, And carry out sequence verification.
SEQ ID NO:2
GTAAAACGACGGCCAGTGAATTCGACATTGATTATTGACTAGTTATTAATAG
SEQ ID NO:3
GCCAAGCTTGGGCTGCAGGTCGAGGGATCTCCATAAGAGAAG
Embodiment 2
Using H9 cell line genome DNA as template, primer target-p-1 (SEQ ID NO:4) and target- is used P-2 (SEQ ID N NO:5) carries out PCR reaction.Response procedures: 98 DEG C initial denaturation 5 minutes;98 DEG C of deformation 10s, 60 DEG C of annealing 15s, 72 DEG C of extension 1min, 35 circulations;72 DEG C of extension 10min.After recycling, target DNA sequence (as target sequence is obtained Column, SEQ ID NO:6).
By the DNA of the plasmid pCIAs of 300ng and restriction enzyme Xba I and Kpn I digestion (respectively 0.5 μ l and 0.5 μ l) mixing, digestion is carried out, 37 DEG C of water-bath 1h obtain linearized vector segment pCIAs after recycling.Use SLIC cloning process Connect above-mentioned 2 segment.By the pCIAs of 100ng and Insert Fragment target sequence according to molar ratio 1:2, the T4DNA of 0.5U is utilized Polymerase is handled 2.5 minutes at room temperature, and subsequent ice bath is simultaneously converted into Escherichia coli, is coated on containing screening on Amp plate Correct clone obtains plasmid target-pCIAs (Fig. 3 a), and carries out sequence verification.
In order to verify whether to be due to caused by DNA sequence dna as a result, being employed herein intragenic one section of HLA-E DNA sequence dna is as DNA sequence dna comparative experiments.According to the process described above, using primer target-1-p-1 (SEQ ID NO: 7) target-1 sequence (SEQ ID N NO:9) is obtained, load is connected to target-1-p-2 (SEQ ID N NO:8), amplification Plasmid target-1-pCIAs (Fig. 3 b) is obtained on body, and carries out sequence verification.
SEQ ID NO:4
GTCTAGACTCCCTGATCGCCTATAGATC
SEQ ID NO:5
CGGTACCCATGAAGAAAGCAGGTGTGGG
SEQ ID NO:6
CATGAAGAAAGCAGGTGTGGGTCCTGGACCAATAGCCCTCCTGAGGTCTGTCCTCAGGGACCTTCCCCT GTGACTTGTGACTGCTGGGATCAGGTCCCATCACCGCCGTAATCAAGGTGATAAATCTGTCCTTCATTTTAACAGGT GCTTTACAAAAGAGTAAGTGCTGGCACACAGGGCCCAGGCTGGGTCGGCCCATGATTGTGGAAGGTGCTTCCCAGTA ATGAGACAGGGCACATTTCTAGCTGGGGCTTGGAACCCTCAGTGAGACAAGAAATCTCAGACCCCACCCTTCACCCC TTCTCCACCTGAGCTCTTCCTCCTCCACATCACGGCAGCGACCACAGCTCCAGTGATCACAGCTCCAAGGAGAACCA GGCCAGCAATGATGCCCACGATGGGGATGGTGGGCTGGGAAGACAGCTCTGGGAAAAGAGGGGAAGGTGAGGGGCCC TGACCCTGCTAAAGGTCTCCAGAGAGGCTCCTGCTTTCCCTAAGAGACATGACACCCCCATCTCCCTCCTTACCCCA TCTCAGGGTGAGGGGCTTGGGCAGACCCTCATGCTGCACATGGCAGGTGTATCTCTGCTCCTCTCCAGAAGGCACCA CCACAGCCGCCCACTTCTGGAAGGTTCCATCCCCTGCAGGCCTGGTCTCCACGAGCTCCGTGTCCTGGGTCTGGTCC TCCCCATCCCGCTGCCAGGTCAGTGTGATCTCCGCAGGGTAGAAGCCCAGGGCCCAGCACCTCAGGGTGGCCTCATG GTCAGAGATGGGGTGGTGGGTCATATGTGTCTTGGGGGGGTCTGACGGGAAGAGTCAGAAAATTCAGGCATTTTGCA TCTGTCATGGGACACTCCACCAGCACGCATGTGGCCATCTTGAGAATGGACAGGACACCCGGGATGGGGAAGAGAGC ACAGAACCCAGACACCAGCCTGGACACAGGCACCTGGGATAATCTTCTATTCCCTGAGAAGGGAACAGCGACTTCTG GTCCTGACCTGAGTGGAGGCTGAGAGACTCAGAAGTGCTGGACTCAGACCCCCACACACATTGAGTGTGAAGCAGAG AACAAGGCCTGAGAGGAAAAGTCACGGGCCCAAGGCTGCTGCCGGTGTCAAAGGGAACCACTCATCAGTATTCGAGG GATCGTCTTCCCGTCACTCCTTCAGAGATTTTATCCCTTAATTGTGTCAGAGAGCAGGGCGGAACCTCAGAGTCACT CTCTGGTACAGGATCTGGAAACCCAGGAGGATTCCTCTCCCTCAGGACCAGAGGGAGGGTGATATTCTAGTGTTGGT CCCAATTGTCTCCCCTCCTTGTGGGAGGCCAGCCCGGGAGATCTATAGGCGATCAGGGAG
SEQ ID NO:7
CGGTACCGCAGACTCAGTTCTCATTCC
SEQ ID NO:8
GTCTAGAGCCTGTGTGGATGCTGAGTG
SEQ ID NO:9
GCAGACTCAGTTCTCATTCCCAATGGGTGTCGGGTTTCTAGAGAAGCCAATCAGCGTCGCCACGACTCC CGACTATAAAGTCCCCATCCGGACTCAAGAAGTTCTCAGGACTCAGAGGCTGGGATCATGGTAGATGGAACCCTCCT TTTACTCCTCTCGGAGGCCCTGGCCCTTACCCAGACCTGGGCGGGTGAGTGCGGGGTCGGGATGGAAACGGCCTCTA CCGGGAGTAGAGAGGGGCCGGCCCGGCGGGGGCGAAGGACTCGGGGAGCCGCGCCGGGAGGAGGGTCGGGCCGATCT CAGCCCCTCCTCGCCCCCAGGCTCCCACTCCTTGAAGTATTTCCACACTTCCGTGTCCCGGCCCGGCCGCGGGGAGC CCCGCTTCATCTCTGTGGGCTACGTGGACGACACCCAGTTCGTGCGCTTCGACAACGACGCCGCGAGTCCGAGGATG GTGCCGCGGGCGCCGTGGATGGAGCAGGAGGGGTCAGAGTATTGGGACCGGGAGACACGGAGCGCCAGGGACACCGC ACAGATTTTCCGAGTGAATCTGCGGACGCTGCGCGGCTACTACAATCAGAGCGAGGCCGGTGAGTGACCCCGGCCAG GGGAGCAGGTCACGACCCCTCCCCATCCCCCACGGACGGCGCGGGTCCCCTCGAATCTTCGGGTCCCAGATTCACCC CAAGGCTGCGGAACCCGCCCAGACCCTAGACCGGGGAGAGTCTCAGGCGCCTTTACCCGGTTCTTTTTCAGTTTAGG CCAAAATGCCCACAGGGTGGTGGCGACGGGGGCGGGGCTTGGTGGGCGGGACTGACTAAGGGGCGGGGCCAGGGTCT CACACCCTGCAGTGGATGCATGGCTGCGAGCTGGGGCCCGACGGGCGCTTCCTCCGCGGGTATGAACAGTTCGCCTA CGACGGCAAGGATTATCTCACCCTGAATGAGGACCTGCGCTCCTGGACCGCGGTGGACACGGCGGCTCAGATCTCCG AGCAAAAGTCAAATGATGCCTCTGAGGCGGAGCACCAGAGAGCCTACCTGGAAGACACATGCGTGGAGTGGCTCCAC AAATACCTGGAGAAGGGGAAGGAGACGCTGCTTCACCTGGGTAAGAGGGTCCACAGGGCTACTCTCCCATCTCCTTC TTGGGCTAGGACTGTGCCCACAGCTGACAGACCTCAAACAGTAGAAGAAACAGGGATGGAGGCCAGAATACCACTCC TCCCTTGGATCAGGAGAGGGAGCTGTCACCTGAGGTACAGGAGATCCTATACCACAGAGTGACTCTCTTAAAGGGCC AGACCTCTCTCAGGGGCAATTAAGGAATCTAGTCTCGCTGGAGATTCCATCCTTCAGATGAACTGATGAGCAGTTCT CTTTGACTCCCAGTATTAGGAATCACGGGGGAGTTTCTCTCGTGCCTGATTCTCAGCCCCACACCAAGAGTTTTTGG AGGTCTGACTCCAGCTTTTCTCAGTCACTCAGCATCCACACAGGC
Embodiment 3
For the cleavage activity of the gRNA of test-target gene.First choice needs to load target gRNA to carrier, required The operation wanted is as follows:
After carrying out gRNA design for target HLA-A gene in the present invention, primer gRNA12b-p-01 (SEQ ID is used NO:10 cycle of annealing) and after gRNA12b-p-02 (SEQ ID NO:11) mixing is executed in PCR instrument, obtains gRNA12b piece Section.
The DNA of the plasmid pHS-Cas 9 of 300ng is mixed with restriction enzyme Kpn I digestion (for 0.5 μ l), is carried out Digestion, 37 DEG C of water-bath 1h obtain linearized vector pHS-Cas 9 after recycling.
Above-mentioned product is connected using T4 ligase, and is converted into Escherichia coli, is coated on containing being screened on Amp plate Correct clone obtains plasmid gRNA12b-pHS-Cas 9 (Fig. 4 a), and carries out sequence verification.
When if necessary to detect more gRNA, then the carriers for being transferred to multiple loading gRNA is needed to can be realized.
In addition, be designed gRNAa to target gene HLA-A, the primer used be gRNAa-p-01 (SEQ ID NO: 12) and gRNAa-p-02 (SEQ ID NO:13), the site cut are to detect and work as purpose sequence not in target sequence It is that red fluorescent protein can be guided to express when arranging the not cleavage site of Cas9/gRNAa, used construction method is above-mentioned Construction method, the present invention construct plasmid gRNAa-pHS-Cas 9 (Fig. 4 b)
Meanwhile according to above design principle, to another section of DNA sequence (SEQ ID NO:9) gene editing in the present invention It is analyzed.Designed gRNA is respectively sg01RNA-pHS-Cas9 (Fig. 4 c) and sg04RNA-pHS-Cas9 (Fig. 4 d).
SEQ ID NO:10
GTGGAAAGGACGAAACACCGCGTGGAGACCAGGCCTGCAG
SEQ ID NO:11
GCTATTTCTAGCTCTAAAACCTGCAGGCCTGGTCTCCACG
SEQ ID NO:12
GTGGAAAGGACGAAACACCGTTACAAGTAAGACCTACTCC
SEQ ID NO:13
GCTATTTCTAGCTCTAAAACGGAGTAGGTCTTACTTGTAA
Embodiment 4
According to the experimental program of Lipofectamine 3000, by plasmid target-pCIAs, gRNA12b-pHS-Cas 9, target-1-pCIAs and sg01RNA-pHS-Cas9 is transferred in HEK293 cell line simultaneously respectively.37 degree of incubated cell 2-4 After it, in fluorescence microscopy microscopic observation cell, it is found that green fluorescence (Fig. 5 a and Fig. 5 c) is presented in cell, illustrate target dna sequence It is to produce frameshift mutation.
The DNA for extracting this cell line, using primer JD-p-1 (SEQ ID NO:14) and JD-p-2 (SEQ ID NO: 15) amplified fragments.Above-mentioned segment is connected using carrier T, converts into Escherichia coli, is coated on containing on Amp plate.By 20 After the random picking of clone spreads cultivation, sequencing company is sent to carry out sequencing verifying.
SEQ ID NO:14
GGTGCCCTCCATGTACAGC
SEQ ID NO:15
CTGCGCCGTTACAGATCCAA
Embodiment 5
According to embodiment 3 and method as described in example 4, plasmid gRNAa-pHS-Cas 9 (Fig. 4 b) and gRNAb- are constructed It pHS-Cas 9 (Fig. 4 d) and goes in HEK293 cell line with target-pCIAs, target-1-pCIAs simultaneously respectively.37 Degree is after incubated cell 2-4 days, in fluorescence microscopy microscopic observation cell, it is found that red fluorescence (Fig. 5 b and Fig. 5 d) is presented in cell, says Bright gRNA sequence does not cut target dna sequence.
The DNA for extracting this cell line, using primer JD-p-1 (SEQ ID No:14) and JD-p-2 (SEQ ID No: 15) amplified fragments.Above-mentioned segment is connected using carrier T, converts into Escherichia coli, is coated on containing on Amp plate.By 20 After the random picking of clone spreads cultivation, sequencing company is sent to carry out sequencing verifying.
It can be seen from the above description that the above embodiments of the present invention realized the following chievements:
1) compared to genome editor's situation in direct testing goal host, plasmid pCIAs constructed by the present invention, when Target DNA sequence is gone to after loading to pCIAs in HEK293 cell line, and the cleavage activity and analysis that can quickly detect gRNA are cut Base sequence after cutting;
2) being using advantage possessed by plasmid constructed by the present invention and detection method being capable of quick, easy detection purpose DNA sequence dna edits situation by different gRNA, can greatly save test period and operation link, reduces experimental cost, makes section Arriving for efficiency is ground to improve;
3) for more gRNA testing requirements, the method for the present invention is also that can provide detection gRNA cleavage activity and edited Genome editor's situation, and analysis OFF-target sequence can be carried out with the presence or absence of situation to be edited.
The foregoing is only a preferred embodiment of the present invention, is not intended to restrict the invention, for the skill of this field For art personnel, the invention may be variously modified and varied.All within the spirits and principles of the present invention, made any to repair Change, equivalent replacement, improvement etc., should all be included in the protection scope of the present invention.
Sequence table
<110>Beijing Sai Bei Bioisystech Co., Ltd
<120>Genetic elements and the application of frameshift mutation are generated for detecting CRISPR/Cas9 gene editing system cutting gene
<130> PN90870SBSW
<160> 15
<170> SIPOSequenceListing 1.0
<210> 1
<211> 7703
<212> DNA
<213>artificial sequence (Artificial Sequence)
<220>
<221> misc_feature
<222> (1)..(7703)
<223>Genetic elements CIAs
<400> 1
tgtaaaacga cggccagtga attcgacatt gattattgac tagttattaa tagtaatcaa 60
ttacggggtc attagttcat agcccatata tggagttccg cgttacataa cttacggtaa 120
atggcccgcc tggctgaccg cccaacgacc cccgcccatt gacgtcaata atgacgtatg 180
ttcccatagt aacgccaata gggactttcc attgacgtca atgggtggag tatttacggt 240
aaactgccca cttggcagta catcaagtgt atcatatgcc aagtacgccc cctattgacg 300
tcaatgacgg taaatggccc gcctggcatt atgcccagta catgacctta tgggactttc 360
ctacttggca gtacatctac gtattagtca tcgctattac catggaatag caacagacat 420
acaaactaaa gaattacaaa aacaaattac aaaaattcaa aattttatcg atactagtaa 480
ggatctgcga tcgctccggt gcccgtcagt gggcagagcg cacatcgccc acagtccccg 540
agaagttggg gggaggggtc ggcaattgaa cgggtgccta gagaaggtgg cgcggggtaa 600
actgggaaag tgatgtcgtg tactggctcc gcctttttcc cgagggtggg ggagaaccgt 660
atataagtgc agtagtcgcc gtgaacgttc tttttcgcaa cgggtttgcc gccagaacac 720
agctgaagct tcgaggggct cgcatctctc cttcacgcgc ccgccgccct acctgaggcc 780
gccatccacg ccggttgagt cgcgttctgc cgcctcccgc ctgtggtgcc tcctgaactg 840
cgtccgccgt ctaggtaagt ttaaagctca ggtcgagacc gggcctttgt ccggcgctcc 900
cttggagcct acctagactc agccggctct ccacgctttg cctgaccctg cttgctcaac 960
tctacgtctt tgtttcgttt tctgttctgc gccgttacag atccaagctg tgaccggcgc 1020
ctacatgtct agannnnnnn nnnnnnnnnn nnnnnnnnnn nnnggtaccg tgtctaaggg 1080
cgaagagctg attaaggaga acatgcacat gaagctgtac atggagggca ccgtgaacaa 1140
ccaccacttc aagtgcacat ccgagggcga aggcaagccc tacgagggca cccagaccat 1200
gagaatcaag gtggtcgagg gcggccctct ccccttcgcc ttcgacatcc tggctaccag 1260
cttcatgtac ggcagcaaaa ccttcatcaa ccacacccag ggcatccccg acttctttaa 1320
gcagtccttc cctgagggct tcacatggga gagagtcacc acatacgaag acgggggcgt 1380
gctgaccgct acccaggaca ccagcctcca ggacggctgc ctcatctaca acgtcaagat 1440
cagaggggtg aacttcccat ccaacggccc tgtgatgcag aagaaaacac tcggctggga 1500
ggcctccacc gagatgctgt accccgctga cggcggcctg gaaggcagaa gcgacatggc 1560
cctgaagctc gtgggcgggg gccacctgat ctgcaacttg aagaccacat acagatccaa 1620
gaaacccgct aagaacctca agatgcccgg cgtctactat gtggacagaa gactggaaag 1680
aatcaaggag gccgacaaag aaacctacgt cgagcagcac gaggtggctg tggccagata 1740
ctgcgacctc cctagcaaac tggggcacaa acttaattaa gccacccagg taatggggca 1800
gtcttctgga ggaggagggc tgtttaccag cagtggcaac attggaatgg ccctgcctaa 1860
cgacatgtat gacttgcatg acctttccaa agctgaactg gccgcacctc agcttattat 1920
gctggcaaat gtggccttaa ctggggaagt aaatggcagc tgctgtgatt acctggtcgg 1980
tgaagaaaga cagatggcag aactgatgcc ggttggggat aacaactttt cagatagtga 2040
agaaggagaa ggacttgaag agtctgctga tataaaaggt gaacctcatg gactggaaaa 2100
catggaactg agaagtttgg aactcagcgt cgtagaacct cagcctgtat ttgaggcatc 2160
aggtgctcca gatatttaca gttcaaataa agatcttccc cctgaaacac ctggagcgga 2220
ggacaaaggc aagagctcga agaccaaacc ctttcgctgt aagccatgcc aatatgaagc 2280
agaatctgaa gaacagtttg tgcatcacat cagagttcac agtgctaaga aattttttgt 2340
ggaagagagt gcagagaagc aggcaaaagc cagggaatct ggctcttcca ctgcagaaga 2400
gggagatttc tccaagggcc ccattcgctg tgaccgctgc ggctacaata ctaatcgata 2460
tgatcactat acagcacacc tgaaacacca caccagagct ggggataatg agcgagtcta 2520
caagtgtatc atttgcacat acacaacagt gagcgagtat cactggagga aacatttaag 2580
aaaccatttt ccaaggaaag tatacacatg tggaaaatgc aactattttt cagacagaaa 2640
aaacaattat gttcagcatg ttagaactca tacaggagaa cgcccatata aatgtgaact 2700
ttgtccttac tcaagttctc agaagactca tctaactaga catatgcgta ctcattcagg 2760
tgagaagcca tttaaatgtg atcagtgcag ttatgtggcc tctaatcaac atgaagtaac 2820
ccgccatgca agacaggttc acaatgggcc taaacctctt aattgcccac actgtgatta 2880
caaaacagca gatagaagca acttcaaaaa acatgtagag ctacatgtga acccacggca 2940
gttcaattgc cctgtatgtg actatgcagc ttccaagaag tgtaatctac agtatcactt 3000
caaatctaag catcctactt gtcctaataa aacaatggat gtctcaaaag tgaaactaaa 3060
gaaaaccaaa aaacgagagg ctgacttgcc tgataatatt accaatgaaa aaacagaaat 3120
agaacaaaca aaaataaaag gggatgtggc tggaaagaaa aatgaaaagt ccgtcaaagc 3180
agagaaaaga gatgtctcaa aagagaaaaa gccttctaat aatgtgtcag tgatccaggt 3240
gactaccaga actcgaaaat cagtaacaga ggtgaaagag atggatgtgc atacaggaag 3300
caattcagaa aaattcagta aaactaagaa aagcaaaagg aagctggaag ttgacagcca 3360
ttctttacat ggtcctgtga atgatgagga atcttcaaca aaaaagaaaa agaaggtaga 3420
aagcaaatcc aaaaataata gtcaggaagt gccaaagggt gacagcaaag tggaggagaa 3480
taaaaagcaa aatacttgca tgaaaaaaag tacaaagaag aaaactctga aaaataaatc 3540
aagtaagaaa agcagtaagc ctcctcagaa ggaacctgtt gagaagggat ctgctcagat 3600
ggaccctcct cagatggggc ctgctcccac agaggcggtt cagaaggggc ccgttcaggt 3660
ggagccgcca cctcccatgg agcatgctca gatggagggt gcccagatac ggcctgctcc 3720
tgacgagcct gttcagatgg aggtggttca ggaggggcct gctcagaagg agctgctgcc 3780
tcccgtggag cctgctcaga tggtgggtgc ccaaattgta cttgctcaca tggagctgcc 3840
tcctcccatg gagactgctc agacggaggt tgcccaaatg gggcctgctc ccatggaacc 3900
tgctcagatg gaggttgccc aggtagaatc tgctcccatg caggtggtcc agaaggagcc 3960
tgttcagatg gagctgtctc ctcccatgga ggtggtccag aaggagcctg ttcagataga 4020
gctgtctcct cccatggagg tggtccagaa ggaacctgtt aagatagagc tgtctcctcc 4080
catagaggtg gtccagaagg agcctgttca gatggagttg tctcctccca tgggggtggt 4140
tcagaaggag cctgctcaga gggagccacc tcctcccaga gagcctcccc ttcacatgga 4200
gccaatttcc aaaaagcctc ctctccgaaa agataaaaag gaaaagtcta acatgcagag 4260
tgaaagggca cggaaggagc aagtccttat tgaagttggc ttagtgcctg ttaaagatag 4320
ctggcttcta aaggaaagtg taagcacaga ggatctctca ccaccatcac caccactgcc 4380
aaaggaaaat ttaagagaag aggcatcagg agaccaaaaa ttactcaaca caggtgaagg 4440
aaataaagaa gcccctcttc agaaagtagg agcagaagag gcagatgaga gcctacctgg 4500
tcttgctgct aatatcaacg aatctaccca tatttcatcc tctggacaaa acttgaatac 4560
gccagagggt gaaactttaa atggtaaaca tcagactgac agtatagttt gtgaaatgaa 4620
aatggacact gatcagaaca caagagagaa tctcactggt ataaattcaa cagttgaaga 4680
accagtttca ccaatgcttc ccccttcagc agtagaagaa cgtgaagcag tgtccaaaac 4740
tgcactggca tcacctcctg ctacaatggc agcaaatgag tctcaggaaa ttgatgaaga 4800
tgaaggcatc cacagccatg aaggaagtga cctaagtgac aacatgtcag agggtagtga 4860
tgattctgga ttgcatgggg ctcggccagt tccacaagaa tctagcagaa aaaatgcaaa 4920
ggaagccttg gcagtcaaag cggctaaggg agattttgtt tgtatcttct gtgatcgttc 4980
tttcagaaag ggaaaagatt acagcaaaca cctcaatcgc catttggtta atgtgtacta 5040
tcttgaagaa gcagctcaag ggcaggagta aagctgaatc taagtcgact taagaaccgc 5100
tcgaggccgg caaggccgga tccagacatg ataagataca ttgatgagtt tggacaaacc 5160
acaactagaa tgcagtgaaa aaaatgcttt atttgtgaaa tttgtgatgc tattgcttta 5220
tttgtaacca ttataagctg caataaacaa gttaacaaca acaattgcat tcattttatg 5280
tttcaggttc agggggaggt gtgggaggtt ttttaaagca agtaaaacct ctacaaatgt 5340
ggtatggctg attatgatct cattcatcct tttctcctcg tccctccttc attcattcat 5400
agccccccgc cctgcccgct tcagcatttc attcattcat tcattcattc atttcccgga 5460
gctccgctag cgcacacccc ttcagccgaa ggccccagcg cgcaggcgca ggccgggaga 5520
ggcaggcacc ctccaatcgt cgggcgtcct tcctcctccg ggcggccgcc cgcttcccca 5580
tgaatgaaca ttgacgtcaa tggggcgggg cgcgcccacg tgaccccgcg cgctcccctt 5640
tataaggcgg tggaggcgcg ggcgctgtcc agcgtgctga agccggagcg agctagccgc 5700
ccggagccgc gccgacccag ctgagcccag cccacgggac gccagacctc gaccgtcgct 5760
cctaccccgg ccaccgctcg gagccgaggc ggacgcgtcc cgatcttccc ctgtccccac 5820
cctgccccga ccctcctctc cacctctcgc gtcgtgacac cagctggtaa atactccgct 5880
gttcgtccct caaaccctcg gcagccagcc gtgggcgtga gggagggttc tctctcctct 5940
cgatgggggt gttgcaaaca cagcggggag ccccctggta agggtccccg gtaaacgggg 6000
gagtcgcagc tttttctctt gctgctgaag tcgcccacgc accatccggg gagtcctacg 6060
gggagggagc agagattttt ttttccccca tattgctgct gcttagtacg tgggcgatgg 6120
cagtgagatg gctcagggaa ggggccgagg aggccctggg taagcgaggg cttcgggggt 6180
tattttccca tttacacggc tccagagatc ggcacaacat cttcctcctt tgctcctaaa 6240
cgttcctctt ctgggtaagg tttgggggat cagggaagcc ccgggtttcc tgctgaaagg 6300
tgggggaagg gaacgtagac ctagagaggg gaattcttac agaaatcctc tttttttggt 6360
cccttctatt tttcagtctc cggcagcctc ttggtcatgg tgagcaaggg cgaggagctg 6420
ttcaccgggg tggtgcccat cctggtcgag ctggacggcg acgtaaacgg ccacaagttc 6480
agcgtgtccg gcgagggcga gggcgatgcc acctacggca agctgaccct gaagttcatc 6540
tgcaccaccg gcaagctgcc cgtgccctgg cccaccctcg tgaccaccct gacctacggc 6600
gtgcagtgct tcagccgcta ccccgaccac atgaagcagc acgacttctt caagtccgcc 6660
atgcccgaag gctacgtcca ggagcgcacc atcttcttca aggacgacgg caactacaag 6720
acccgcgccg aggtgaagtt cgagggcgac accctggtga accgcatcga gctgaagggc 6780
atcgacttca aggaggacgg caacatcctg gggcacaagc tggagtacaa ctacaacagc 6840
cacaacgtct atatcatggc cgacaagcag aagaacggca tcaaggtgaa cttcaagatc 6900
cgccacaaca tcgaggacgg cagcgtgcag ctcgccgacc actaccagca gaacaccccc 6960
atcggcgacg gccccgtgct gctgcccgac aaccactacc tgagcaccca gtccgccctg 7020
agcaaagacc ccaacgagaa gcgcgatcac atggtcctgc tggagttcgt gaccgccgcc 7080
gggatcactc tcggcatgga cgagctgtac aagtaaacgc gtgaattcac tcctcaggtg 7140
caggctgcct atcagaaggt ggtggctggt gtggccaatg ccctggctca caaataccac 7200
tgagatcttt ttccctctgc caaaaattat ggggacatca tgaagcccct tgagcatctg 7260
acttctggct aataaaggaa atttattttc attgcaatag tgtgttggaa ttttttgtgt 7320
ctctcactcg gaaggacata tgggagggca aatcatttaa aacatcagaa tgagtatttg 7380
gtttagagtt tggcaacata tgcccatatg ctggctgcca tgaacaaagg ttggctataa 7440
agaggtcatc agtatatgaa acagccccct gctgtccatt ccttattcca tagaaaagcc 7500
ttgacttgag gttagatttt ttttatattt tgttttgtgt tatttttttc tttaacatcc 7560
ctaaaatttt ccttacatgt tttactagcc agatttttcc tcctctcctg actactccca 7620
gtcatagctg tccctcttct cttatggaga tccctcgacc tgcagcccaa gcttggcgta 7680
atcatggtca tagctgtttc ctg 7703
<210> 2
<211> 52
<212> DNA
<213>artificial sequence (Artificial Sequence)
<220>
<221> primer_bind
<222> (1)..(52)
<223>primer CIA-P1
<400> 2
gtaaaacgac ggccagtgaa ttcgacattg attattgact agttattaat ag 52
<210> 3
<211> 42
<212> DNA
<213>artificial sequence (Artificial Sequence)
<220>
<221> primer_bind
<222> (1)..(42)
<223>primer CIA-P2
<400> 3
gccaagcttg ggctgcaggt cgagggatct ccataagaga ag 42
<210> 4
<211> 28
<212> DNA
<213>artificial sequence (Artificial Sequence)
<220>
<221> primer_bind
<222> (1)..(28)
<223>primer target-p-1
<400> 4
gtctagactc cctgatcgcc tatagatc 28
<210> 5
<211> 28
<212> DNA
<213>artificial sequence (Artificial Sequence)
<220>
<221> primer_bind
<222> (1)..(28)
<223>primer target-p-2
<400> 5
cggtacccat gaagaaagca ggtgtggg 28
<210> 6
<211> 1361
<212> DNA
<213>artificial sequence (Artificial Sequence)
<220>
<221> misc_feature
<222> (1)..(1361)
<223>target DNA sequence
<400> 6
catgaagaaa gcaggtgtgg gtcctggacc aatagccctc ctgaggtctg tcctcaggga 60
ccttcccctg tgacttgtga ctgctgggat caggtcccat caccgccgta atcaaggtga 120
taaatctgtc cttcatttta acaggtgctt tacaaaagag taagtgctgg cacacagggc 180
ccaggctggg tcggcccatg attgtggaag gtgcttccca gtaatgagac agggcacatt 240
tctagctggg gcttggaacc ctcagtgaga caagaaatct cagaccccac ccttcacccc 300
ttctccacct gagctcttcc tcctccacat cacggcagcg accacagctc cagtgatcac 360
agctccaagg agaaccaggc cagcaatgat gcccacgatg gggatggtgg gctgggaaga 420
cagctctggg aaaagagggg aaggtgaggg gccctgaccc tgctaaaggt ctccagagag 480
gctcctgctt tccctaagag acatgacacc cccatctccc tccttacccc atctcagggt 540
gaggggcttg ggcagaccct catgctgcac atggcaggtg tatctctgct cctctccaga 600
aggcaccacc acagccgccc acttctggaa ggttccatcc cctgcaggcc tggtctccac 660
gagctccgtg tcctgggtct ggtcctcccc atcccgctgc caggtcagtg tgatctccgc 720
agggtagaag cccagggccc agcacctcag ggtggcctca tggtcagaga tggggtggtg 780
ggtcatatgt gtcttggggg ggtctgacgg gaagagtcag aaaattcagg cattttgcat 840
ctgtcatggg acactccacc agcacgcatg tggccatctt gagaatggac aggacacccg 900
ggatggggaa gagagcacag aacccagaca ccagcctgga cacaggcacc tgggataatc 960
ttctattccc tgagaaggga acagcgactt ctggtcctga cctgagtgga ggctgagaga 1020
ctcagaagtg ctggactcag acccccacac acattgagtg tgaagcagag aacaaggcct 1080
gagaggaaaa gtcacgggcc caaggctgct gccggtgtca aagggaacca ctcatcagta 1140
ttcgagggat cgtcttcccg tcactccttc agagatttta tcccttaatt gtgtcagaga 1200
gcagggcgga acctcagagt cactctctgg tacaggatct ggaaacccag gaggattcct 1260
ctccctcagg accagaggga gggtgatatt ctagtgttgg tcccaattgt ctcccctcct 1320
tgtgggaggc cagcccggga gatctatagg cgatcaggga g 1361
<210> 7
<211> 27
<212> DNA
<213>artificial sequence (Artificial Sequence)
<220>
<221> primer_bind
<222> (1)..(27)
<223>primer target-1-p-1
<400> 7
cggtaccgca gactcagttc tcattcc 27
<210> 8
<211> 27
<212> DNA
<213>artificial sequence (Artificial Sequence)
<220>
<221> primer_bind
<222> (1)..(27)
<223>primer target-1-p-2
<400> 8
gtctagagcc tgtgtggatg ctgagtg 27
<210> 9
<211> 1500
<212> DNA
<213>artificial sequence (Artificial Sequence)
<220>
<221> misc_feature
<222> (1)..(1500)
<223>target-1 sequence
<400> 9
gcagactcag ttctcattcc caatgggtgt cgggtttcta gagaagccaa tcagcgtcgc 60
cacgactccc gactataaag tccccatccg gactcaagaa gttctcagga ctcagaggct 120
gggatcatgg tagatggaac cctcctttta ctcctctcgg aggccctggc ccttacccag 180
acctgggcgg gtgagtgcgg ggtcgggatg gaaacggcct ctaccgggag tagagagggg 240
ccggcccggc gggggcgaag gactcgggga gccgcgccgg gaggagggtc gggccgatct 300
cagcccctcc tcgcccccag gctcccactc cttgaagtat ttccacactt ccgtgtcccg 360
gcccggccgc ggggagcccc gcttcatctc tgtgggctac gtggacgaca cccagttcgt 420
gcgcttcgac aacgacgccg cgagtccgag gatggtgccg cgggcgccgt ggatggagca 480
ggaggggtca gagtattggg accgggagac acggagcgcc agggacaccg cacagatttt 540
ccgagtgaat ctgcggacgc tgcgcggcta ctacaatcag agcgaggccg gtgagtgacc 600
ccggccaggg gagcaggtca cgacccctcc ccatccccca cggacggcgc gggtcccctc 660
gaatcttcgg gtcccagatt caccccaagg ctgcggaacc cgcccagacc ctagaccggg 720
gagagtctca ggcgccttta cccggttctt tttcagttta ggccaaaatg cccacagggt 780
ggtggcgacg ggggcggggc ttggtgggcg ggactgacta aggggcgggg ccagggtctc 840
acaccctgca gtggatgcat ggctgcgagc tggggcccga cgggcgcttc ctccgcgggt 900
atgaacagtt cgcctacgac ggcaaggatt atctcaccct gaatgaggac ctgcgctcct 960
ggaccgcggt ggacacggcg gctcagatct ccgagcaaaa gtcaaatgat gcctctgagg 1020
cggagcacca gagagcctac ctggaagaca catgcgtgga gtggctccac aaatacctgg 1080
agaaggggaa ggagacgctg cttcacctgg gtaagagggt ccacagggct actctcccat 1140
ctccttcttg ggctaggact gtgcccacag ctgacagacc tcaaacagta gaagaaacag 1200
ggatggaggc cagaatacca ctcctccctt ggatcaggag agggagctgt cacctgaggt 1260
acaggagatc ctataccaca gagtgactct cttaaagggc cagacctctc tcaggggcaa 1320
ttaaggaatc tagtctcgct ggagattcca tccttcagat gaactgatga gcagttctct 1380
ttgactccca gtattaggaa tcacggggga gtttctctcg tgcctgattc tcagccccac 1440
accaagagtt tttggaggtc tgactccagc ttttctcagt cactcagcat ccacacaggc 1500
<210> 10
<211> 40
<212> DNA
<213>artificial sequence (Artificial Sequence)
<220>
<221> primer_bind
<222> (1)..(40)
<223>primer gRNA12b-p-01
<400> 10
gtggaaagga cgaaacaccg cgtggagacc aggcctgcag 40
<210> 11
<211> 40
<212> DNA
<213>artificial sequence (Artificial Sequence)
<220>
<221> primer_bind
<222> (1)..(40)
<223>primer gRNA12b-p-02
<400> 11
gctatttcta gctctaaaac ctgcaggcct ggtctccacg 40
<210> 12
<211> 40
<212> DNA
<213>artificial sequence (Artificial Sequence)
<220>
<221> primer_bind
<222> (1)..(40)
<223>primer gRNAa-p-01
<400> 12
gtggaaagga cgaaacaccg ttacaagtaa gacctactcc 40
<210> 13
<211> 40
<212> DNA
<213>artificial sequence (Artificial Sequence)
<220>
<221> primer_bind
<222> (1)..(40)
<223>primer gRNAa-p-02
<400> 13
gctatttcta gctctaaaac ggagtaggtc ttacttgtaa 40
<210> 14
<211> 19
<212> DNA
<213>artificial sequence (Artificial Sequence)
<220>
<221> primer_bind
<222> (1)..(19)
<223>primer JD-p-1
<400> 14
ggtgccctcc atgtacagc 19
<210> 15
<211> 20
<212> DNA
<213>artificial sequence (Artificial Sequence)
<220>
<221> primer_bind
<222> (1)..(20)
<223>primer JD-p-2
<400> 15
ctgcgccgtt acagatccaa 20

Claims (17)

1. a kind of Genetic elements for generating frameshift mutation for detecting CRISPR/Cas9 gene editing system cutting gene, special Sign is, the Genetic elements include the promoter effectively connected, the first reporter gene, REST gene, SV40pA gene, S heavy Silent son, the second reporter gene and terminator, wherein can be inserted between the promoter and the first reporter gene by cutting mesh DNA sequence dna is marked, first reporter gene is different from second reporter gene, and the expression of the REST gene is able to suppress institute State the expression of the second reporter gene behind S silencer.
2. Genetic elements according to claim 1, which is characterized in that the Genetic elements further include the enhancing effectively connected Son.
3. Genetic elements according to claim 2, which is characterized in that the enhancer is cmv enhancer.
4. Genetic elements according to claim 1, which is characterized in that first reporter gene is red fluorescent protein base Cause, second reporter gene are green fluorescence protein gene.
5. Genetic elements according to claim 1, which is characterized in that the promoter is EF1 promoter, the terminator For beta-globin polyadenylic acid.
6. Genetic elements according to claim 1, which is characterized in that the Genetic elements contain double enzyme site, described Double enzyme site be located at the promoter and it is described first report between, it is described can be connected to by cutting target dna sequence it is described Between double enzyme site.
7. Genetic elements according to claim 6, which is characterized in that the double enzyme site is Xba I and Kpn I digestion Site.
8. Genetic elements according to claim 1, which is characterized in that the REST gene and the S silencer amplification in Source of people H9 cell line.
9. Genetic elements according to claim 1, which is characterized in that the Genetic elements have such as SEQ ID NO:1 institute The nucleotide sequence shown.
10. a kind of carrier for generating frameshift mutation for detecting CRISPR/Cas9 gene editing system cutting gene, feature exist In the carrier includes Genetic elements as claimed in any one of claims 1-9 wherein.
11. carrier according to claim 10, which is characterized in that the carrier be pUC serial carrier, pEASY, PBlueScriptII or pBR322.
12. a kind of host cell, which is characterized in that including as described in claim 10 or 11 for detecting CRISPR/Cas9 Gene editing system cuts the carrier that gene generates frameshift mutation.
13. host cell according to claim 12, which is characterized in that the host cell is Escherichia coli.
14. a kind of method that detection CRISPR/Cas9 gene editing system cutting gene generates frameshift mutation, which is characterized in that Frameshift mutation is generated for detecting CRISPR/Cas9 gene editing system cutting gene using as described in claim 10 or 11 Carrier detected.
15. according to the method for claim 14, which comprises the following steps:
Carrier as described in claim 10 or 11 is inserted by cutting target dna sequence, then transfects into cell line by S1, It is transferred to the carrier for being mounted with gRNA simultaneously, the carrier for being mounted with gRNA also includes the DNA sequence dna for expressing Cas9 albumen;
S2 observes the expression of the first reporter gene and the second reporter gene, is reported according to first reporter gene and second The expression for accusing gene judges whether gRNA produces frameshift mutation to the editor of target dna sequence.
16. according to the method for claim 15, which is characterized in that further include: when the second reporter gene normal expression When, it is judged as that CRISPR/Cas9 gene editing system cutting gene produces frameshift mutation, and expand the target dna sequence It is sequenced.
17. according to the method for claim 15, which is characterized in that the cell line is HEK293 cell line.
CN201811320658.5A 2018-11-07 2018-11-07 Genetic elements and the application of frameshift mutation are generated for detecting CRISPR/Cas9 gene editing system cutting gene Pending CN109371167A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201811320658.5A CN109371167A (en) 2018-11-07 2018-11-07 Genetic elements and the application of frameshift mutation are generated for detecting CRISPR/Cas9 gene editing system cutting gene

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201811320658.5A CN109371167A (en) 2018-11-07 2018-11-07 Genetic elements and the application of frameshift mutation are generated for detecting CRISPR/Cas9 gene editing system cutting gene

Publications (1)

Publication Number Publication Date
CN109371167A true CN109371167A (en) 2019-02-22

Family

ID=65384303

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201811320658.5A Pending CN109371167A (en) 2018-11-07 2018-11-07 Genetic elements and the application of frameshift mutation are generated for detecting CRISPR/Cas9 gene editing system cutting gene

Country Status (1)

Country Link
CN (1) CN109371167A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110656123A (en) * 2019-10-12 2020-01-07 中国农业大学 Method for screening sgRNA high-efficiency action target based on CRISPR-Cas13d system and application
CN111471744A (en) * 2020-05-14 2020-07-31 重庆英茂盛业生物科技有限公司 Method for detecting gene editing target point cutting efficiency
WO2025071493A1 (en) * 2023-09-29 2025-04-03 Agency For Science, Technology And Research Dna construct and nucleic acid compound tools

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105647968A (en) * 2016-02-02 2016-06-08 浙江大学 Fast CRISPR-Cas9 working efficiency testing system and application thereof
US20160304872A1 (en) * 2015-04-16 2016-10-20 California Institute Of Technology Fractional regulation of transcription
CN106636154A (en) * 2015-10-30 2017-05-10 中国科学院上海生命科学研究院 Efficient sgRNA screening system and efficient sgRNA screening method

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160304872A1 (en) * 2015-04-16 2016-10-20 California Institute Of Technology Fractional regulation of transcription
CN106636154A (en) * 2015-10-30 2017-05-10 中国科学院上海生命科学研究院 Efficient sgRNA screening system and efficient sgRNA screening method
CN105647968A (en) * 2016-02-02 2016-06-08 浙江大学 Fast CRISPR-Cas9 working efficiency testing system and application thereof

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
PETER EISENHUT,ET AL.: "A CRISPR/Cas9 based engineering strategy for overexpression of multiple genes in Chinese hamster ovary cells", 《METABOLIC ENGINEERING》 *
刘庆斌等: "不止是沉默-神经元限制性沉默因子及其作用元件的研究进展", 《生理科学进展》 *
陈妍等: "负调控元件-沉默子", 《遗传》 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110656123A (en) * 2019-10-12 2020-01-07 中国农业大学 Method for screening sgRNA high-efficiency action target based on CRISPR-Cas13d system and application
CN110656123B (en) * 2019-10-12 2021-07-13 中国农业大学 Screening method and application of sgRNA high-efficiency target based on CRISPR-Cas13d system
CN111471744A (en) * 2020-05-14 2020-07-31 重庆英茂盛业生物科技有限公司 Method for detecting gene editing target point cutting efficiency
WO2025071493A1 (en) * 2023-09-29 2025-04-03 Agency For Science, Technology And Research Dna construct and nucleic acid compound tools

Similar Documents

Publication Publication Date Title
CN108441519A (en) The method that homologous remediation efficiency is improved in CRISPR/CAS9 gene editings
WO2015100929A1 (en) Method for constructing eukaryotic gene knockout library by using crispr/cas9 system
KR102365484B1 (en) Improved recombinant protein expression using a hybrid chef1 promoter
CN110295149B (en) A mutant strain type 3 duck hepatitis A virus CH-P60-117C strain and construction method
CN116209674A (en) KRAB fusion repressors and methods and compositions for repressing gene expression
CN109371167A (en) Genetic elements and the application of frameshift mutation are generated for detecting CRISPR/Cas9 gene editing system cutting gene
KR20060123413A (en) Expression system using mammalian β actin promoter
CN101260408B (en) Construction method and application of two-color fluorescence report carrier
CN109321571A (en) A method of utilizing CRISPR/Cas9 preparation and reorganization porcine pseudorabies virus
CN112029736B (en) Recombinant pseudorabies virus live vaccine for preventing African swine fever and preparation method thereof
CN112961219B (en) Recombinant adeno-associated virus, its mutant and its construction method and application
CN109055375B (en) Method for activating gene expression by CRISPR (clustered regularly interspaced short palindromic repeats) auxiliary trans-enhancer and application of method
CN101121939B (en) Universal green fluorescence protein fusion target gene expression vector for siRNA screening system
CN114350615B (en) STAT2 gene deletion cell strain and preparation method and application thereof
CN101705246B (en) Lentiviral gene transfer vector, preparation method and application thereof
CN114395017B (en) Preparation method and application of SARS-CoV-2 virus-like particle
CN114369619A (en) Reporter vector and vector system for gene knockout and application
CN110295180B (en) Type 3 duck hepatitis A virus mutant gene ISA-A117C-C4334A and construction method thereof
CN110684781B (en) A kind of type 3 duck hepatitis A virus mutant gene ISA-A117C-T1142A and construction method
KR102427400B1 (en) Establishment of a major allergen, Fel d 1 targeted feline cell line
CN104195153A (en) Bicistronic co-expression gene transfer bodyand preparation method
CN110564765B (en) Homologous recombination vector and recombinant cell for expressing eGFP, and preparation method and application thereof
CN102994550A (en) Method for expressing exogenous gene in animal cell or animal tissue
CN110283835B (en) Type 3 duck hepatitis A virus mutant gene ISA-T1142A-C4334A and construction method
CN103131709A (en) Ribonucleic acid (RNA) interference fragment of zinc finger-x (zfx) gene and application of RNA interference fragment in mouse sex control

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination